Cleaved PARP Recombinant Rabbit Monoclonal Antibody [SU0314]
Overview
Product Name
Cleaved PARP Recombinant Rabbit Monoclonal Antibody [SU0314]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human PARP1 aa 200-249 / 1,014.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IP
Molecular Weight
Predicted band size: 89 kDa
Positive Control
Jurkat cell lysate, A549 cell lysate, Hela, Daudi cell lysates.
Conjugation
unconjugated
Clone Number
SU0314
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IF-Cell
-
1:100-1:250
-
IP
-
1-2μg/sample
Target
Function
Poly (ADP-ribose) polymerase (PARP) is a family of proteins involved in a number of cellular processes such as DNA repair, genomic stability, and programmed cell death. The main role of PARP (found in the cell nucleus) is to detect and initiate an immediate cellular response to metabolic, chemical, or radiation-induced single-strand DNA breaks (SSB) by signaling the enzymatic machinery involved in the SSB repair. Once PARP detects a SSB, it binds to the DNA, undergoes a structural change, and begins the synthesis of a polymeric adenosine diphosphate ribose (poly (ADP-ribose) or PAR) chain, which acts as a signal for the other DNA-repairing enzymes. Target enzymes include DNA ligase III (LigIII), DNA polymerase beta (polβ), and scaffolding proteins such as X-ray cross-complementing gene 1 (XRCC1). After repairing, the PAR chains are degraded via Poly(ADP-ribose) glycohydrolase (PARG). PARP enzymes are essential in a number of cellular functions, including expression of inflammatory genes: PARP1 is required for the induction of ICAM-1 gene expression by cardiac myocytes and smooth muscle cells, in response to TNF.
Background References
1. Peh J et al. The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas. Mol Cancer Ther 15:1859-69 (2016).
2. Gao L et al. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front Pharmacol 6:215 (2015).
Post-translational Modification
Phosphorylated by PRKDC and TXK.; Poly-ADP-ribosylated on glutamate and aspartate residues by autocatalysis. Poly-ADP-ribosylated by PARP2; poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites. ADP-ribosylated on serine by autocatalysis; serine ADP-ribosylation takes place following interaction with HPF1.; S-nitrosylated, leading to inhibit transcription regulation activity.
Subcellular Location
Nucleus.
UNIPROT
Synonyms
ADP-ribosyltransferase diphtheria toxin-like 1 antibody
ADPRT 1 antibody
ADPRT antibody
ADPRT1 antibody
APOPAIN antibody
ARTD1 antibody
NAD(+) ADP-ribosyltransferase 1 antibody
PARP antibody
PARP-1 antibody
PARP1 antibody
ExpandADP-ribosyltransferase diphtheria toxin-like 1 antibody
ADPRT 1 antibody
ADPRT antibody
ADPRT1 antibody
APOPAIN antibody
ARTD1 antibody
NAD(+) ADP-ribosyltransferase 1 antibody
PARP antibody
PARP-1 antibody
PARP1 antibody
PARP1_HUMAN antibody
Poly [ADP-ribose] polymerase 1 antibody
Poly ADP ribose polymerase 1 antibody
Poly[ADP-ribose] synthase 1 antibody
PPOL antibody
SCA1 antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Cleaved PARP on different lysates with Rabbit anti-Cleaved PARP antibody (ET1608-10) at 1/2,000 dilution.
Lane 1: HeLa whole cell lysate
Lane 2: HeLa treated with 1μM staurosporine for 3 hours whole cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 89 kDa
Observed band size: 89 kDa
Exposure time: 1 minute 9 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-10) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of Cleaved PARP on different lysates with Rabbit anti-Cleaved PARP antibody (ET1608-10) at 1/500 dilution.
Lane 1: Hela-si NT cell lysate (10 µg/Lane)
Lane 2: Hela-si Cleaved PARP cell lysate (10 µg/Lane)
Predicted band size: 89 kDa
Observed band size: 89 kDa
Exposure time: 3 minutes;
4-20% SDS-PAGE gel.
ET1608-10 was shown to specifically react with Cleaved PARP in Hela-si NT cells. No band was observed when Hela-si Cleaved PARP sample was tested. Hela-si NT and Hela-si Cleaved PARP samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1608-10, 1/500) and Loading control antibody (Rabbit anti-GAPDH, ET1601-4, 1/10,000) were used in 5% BSA at room temperature for 2 hours. Goat Anti-rabbit IgG-HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of HeLa cells treated with 1μM staurosporine for 180 minutes labeling Cleaved PARP with Rabbit anti-Cleaved PARP antibody (ET1608-10) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cleaved PARP antibody (ET1608-10) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Cleaved PARP was immunoprecipitated from 0.2 mg Daudi cell lysate with ET1608-10 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1608-10 at 1/500 dilution. HRP Conjugated Anti-Rabbit IgG for IP Nano-secondary antibody at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: Daudi cell lysate (input)
Lane 2: ET1608-10 IP in Daudi cell lysate
Lane 3: Rabbit IgG instead of ET1608-10 in Daudi cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 12 seconds; ECL: K1801
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-026-45597-9
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death
Journal: Cell Communication And Signaling
DOI: 10.1186/s12964-026-02688-4
IF: 8.9
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Inhibition of Cathepsin B protects against vandetanib-induced hepato-cardiotoxicity by restoring lysosomal damage
Journal: International Journal Of Biological Sciences
DOI: 10.7150/ijbs.122904
IF: 10
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Cathayanon E induces apoptosis and enhances oxaliplatin sensitivity in colorectal cancer through suppression of MCL1
Journal: Apoptosis
DOI: 10.1007/s10495-025-02167-0
IF: 8.1
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
HDAC2 promotes malignant progression by the RBM47/NONO axis in medulloblastoma
Journal: Translational Oncology
DOI: 10.1016/j.tranon.2025.102549
IF: 4.1
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity
Journal: Autophagy
DOI: 10.1080/15548627.2025.2576619
IF: 14.3
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
Off-target engagement of sotorasib with PPARγ via FABP4: a novel mechanism driving interstitial lung disease
Journal: Cell Communication And Signaling
DOI: 10.1186/s12964-025-02425-3
IF: 8.9
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1
Journal: Toxicology And Applied Pharmacology
DOI: 10.1016/j.taap.2025.117630
IF: 3.4
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
A novel sulfonamide derivative suppresses gastrointestinal cancer progression by targeting Axin2 and β-catenin
Journal: Scientific Reports
DOI: 10.1038/s41598-025-25904-6
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Paris saponin VII restrains PD-L1 mediated immune evasion through the AKT1 and STAT3 signaling pathways
Journal: Chemico-Biological Interactions
DOI: 10.1016/j.cbi.2025.111562
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Piperlongumine Inhibits Malignant Progression of Esophageal Squamous Cells Through the PI3K/AKT Signaling Pathway
Journal: Biochemical Genetics
DOI: 10.1007/s10528-025-11139-7
IF: 2.1
Application: WB
Reactivity: Human
Publish date: 2025 May
-
ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma
Journal: International Journal Of Biochemistry & Cell Biology
DOI: 10.1016/j.biocel.2025.106804
IF: 3.4
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Ethanol Extract of Adlay Hulls Suppresses Acute Myeloid Leukemia Cell Proliferation via PI3K/Akt Pathway Inhibition
Journal: Current Issues In Molecular Biology
DOI: 10.3390/cimb47050358
IF: 2.8
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Alkannin triggered apoptosis and ferroptosis in gastric cancer by suppressing lipid metabolism mediated by the c-Fos/SREBF1 axis
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.156604
IF: 6.7
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination-Dependent Degradation
Journal: Cancer Science
DOI: 10.1111/cas.70061
IF: 4.5
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Engineered copper-doped gold nanoclusters supported ROS prolongation for enhanced photodynamic therapy
Journal: Materials & Design
DOI: 10.1016/j.matdes.2025.114287
IF: 7.9
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
The novel HDAC6 inhibitor 9r induces anti-tumor responses by enhancing T cell response and inducing MHC class II signaling pathways in esophageal cancer
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115076
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Metallothioneins protect against isoconazole nitrate-induced antitumor activity through the maintenance of cellular redox homeostasis in hepatocellular carcinoma
Journal: Chemico-Biological Interactions
DOI: 10.1016/j.cbi.2025.111614
IF: 5.4
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Targeting DKC1/NF-κB axis suppresses tumorigenesis and enhances 5-FU sensitivity in gastric cancer
Journal: Cancer Cell International
DOI: 10.1186/s12935-025-03926-4
IF: 6
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Endogenous Protein-Modified Gold Nanorods as Immune-Inert Biomodulators for Tumor-Specific Imaging and Therapy
Journal: Advanced Healthcare Materials
DOI: 10.1002/adhm.202404548
IF: 9.6
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jan
-
Maackiain induces apoptosis and autophagy via ROS-mediated endoplasmic reticulum stress in endometrial cancer
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY
DOI: 10.1016/j.intimp.2024.113935
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity
Journal: Advanced Science
DOI: 10.1002/advs.202414923
IF: 14.1
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jan
-
Endogenous Protein-Modified Gold Nanorods as Immune-Inert Biomodulators for Tumor-Specific Imaging and Therapy
Journal: Advanced Healthcare Materials
DOI:
IF: 10
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jan
-
Maackiain induces apoptosis and autophagy via ROS-mediated endoplasmic reticulum stress in endometrial cancer
Journal: International Immunopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity
Journal: Advanced Science
DOI:
IF: 14.3
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jan
-
GPER agonist G-1 activates YAP to induce apoptosis in breast cancer cells
Journal: Journal Of Steroid Biochemistry And Molecular Biology
DOI: 10.1016/j.jsbmb.2025.106693
IF: 2.7
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Promoting the transition from pyroptosis to apoptosis in endothelial cells: a novel approach to alleviate methylglyoxal-induced vascular damage
Journal: Journal Of Translational Medicine
DOI: 10.1186/s12967-025-06195-x
IF: 6.1
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
PEX11B palmitoylation couples peroxisomal dysfunction with Schwann cells fail in diabetic neuropathy
Journal: Journal Of Biomedical Science
DOI: 10.1186/s12929-024-01115-5
IF: 9
Application: WB
Reactivity: Rat
Publish date: 2025 Feb
-
Centipeda minima extract exhibits anti-liver cancer effects via the ER stress/HMOX1/Fe2+/ROS pathway
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.156487
IF: 6.7
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Capilliposide A relieved dry age-related macular degeneration through ROS/SIRT1/P53 signaling pathway
Journal: European Journal Of Pharmacology
DOI: 10.1016/j.ejphar.2025.177412
IF: 4.2
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Feb
-
MEK inhibitor induces cardiac complications by preventing ZMYND8-mediated ubiquitination and proteasomal degradation of HMGB1
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.117660
IF: 5.6
Application: WB
Reactivity: Human
Publish date: 2025 Dec
-
A methyl-to-acetyl switch in H3K27 drives metabolic reprogramming and resistance to BRAFV600E inhibition in melanoma
Journal: Neoplasia
DOI: 10.1016/j.neo.2025.101223
IF: 7.7
Application: WB
Reactivity: Human,Mouse
Publish date: 2025 Aug
-
Hydroxyl-augmented gold nanorods via lactone ring-opening alleviate cisplatin nephrotoxicity through Nrf2 activation
Journal: Biomaterials
DOI: 10.1016/j.biomaterials.2025.123596
IF: 12.9
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
Curcumol Ameliorates Cisplatin-induced Nephrotoxicity by Targeting TAK1 and Inhibiting MAPK and NF-κB Pathways
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.156752
IF: 6.7
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Apr
-
FAT1 Enhances the Sensitivity of Non-Small Cell Lung Cancer to VCP Inhibitors by Regulating the Activation of the Endoplasmic Reticulum Stress Pathway
Journal: FASEB Journal
DOI: 10.1096/fj.202500097RR
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Heme oxygenase 1 confers gilteritinib resistance in FLT3-ITD acute myeloid leukemia in a STAT6-dependent manner
Journal: Cancer Cell International
DOI: 10.1186/s12935-025-03757-3
IF: 5.3
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Schisandrin C prevents Regorafenib-Induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes
Journal: Toxicological Sciences
DOI: 10.1093/toxsci/kfae127
IF: 3.4
Application: WB
Reactivity: Human,Rat
Publish date: 2024 Sept
-
The role of apoptosis, immunogenic cell death, and macrophage polarization in carbon ion radiotherapy for keloids: Targeting the TGF-β1/SMADs signaling pathway
Journal: Molecular Basis Of Disease
DOI: https://doi.org/10.1016/j.bbadis.2024.167499
IF:
Application: WB
Reactivity: Mouse
Publish date: 2024 Sep
-
A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth
Journal: Acta Pharmacologica Sinica
DOI:
IF: 6.9
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Dabrafenib Alleviates Hepatotoxicity Caused by Lenvatinib via Inhibiting the Death Receptor Signaling Pathway
Journal: Toxicology Letters
DOI:
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2024 May
-
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction
Journal: Molecular Neurobiology
DOI:
IF: 5.1
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
hnRNPH1 maintains mitochondrial homeostasis by establishing NRF1/DRP1 retrograde signaling under mitochondrial stress
Journal: Cell Death & Differentiation
DOI:
IF: 13.7
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Exploring the Potential of Thiophene Derivatives as Dual Inhibitors of β-Tubulin and Wnt/β-Catenin Pathways for Gastrointestinal Cancers in Vitro
Journal: Heliyon
DOI:
IF: 4
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
The Combination of Gefitinib and Acetaminophen Exacerbates Hepatotoxicity via ROS-Mediated Apoptosis
Journal: Biomolecules & Therapeutics
DOI: 10.4062/biomolther.2023.209
IF: 3
Application:
Reactivity:
Publish date: 2024 Jun
-
Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma
Journal: Oral Diseases
DOI:
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2024 Jul
-
The Long Non-Coding RNA NR3C2-8: 1 Promotes p53-Mediated Apoptosis through the miR-129-5p/USP10 Axis in Amyotrophic Lateral Sclerosis
Journal: Molecular Neurobiology
DOI:
IF: 5.1
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
Screening of anti-melanoma compounds from Morus alba L.: Sanggenon C promotes melanoma cell apoptosis by disrupting intracellular Ca2+ homeostasis
Journal: Journal Of Ethnopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
Evodiamine Inhibits the Progression of Esophageal Aquamous Cell Carcinoma via Modulating PI3K/AKT/mTOR Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI: 10.21203/rs.3.rs-4133300/v1
IF:
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
Modulation of epithelial-mesenchymal transition by gemcitabine: Targeting ionizing radiation-induced cellular senescence in lung cancer cell
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
Inhibition of PRKAA/AMPK (Ser485/491) phosphorylation by crizotinib induces cardiotoxicity via perturbing autophagosome-lysosome fusion
Journal: Autophagy
DOI: 10.1080/15548627.2023.2259216
IF: 13.3
Application: WB
Reactivity: Human,Mouse
Publish date: 2023 Oct
-
Elucidation of the anti-colon cancer mechanism of Phellinus baumii polyphenol by an integrative approach of network pharmacology and experimental verification
Journal: International Journal Of Biological Macromolecules
DOI:
IF: 8.2
Application: WB
Reactivity: Human
Publish date: 2023 Oct
-
Circular RNA ZBTB46 depletion alleviates the progression of Atherosclerosis by regulating the ubiquitination and degradation of hnRNPA2B1 via the AKT/mTOR pathway
Journal: Immunity & Ageing
DOI: 10.1186/s12979-023-00386-0
IF: 7.9
Application: WB
Reactivity: Human
Publish date: 2023 Nov
-
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis
Journal: Nature Communications
DOI:
IF: 17.694
Application: WB
Reactivity: Mouse
Publish date: 2023 May
-
Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway
Journal: Journal Of Zhejiang University-Science B
DOI:
IF: 5.1
Application: WB
Reactivity: Human
Publish date: 2023 Mar
-
Apatinib Inhibits Bladder Cancer through Suppression of the VEGFR2-PI3K-AKT Signaling Pathway as Revealed by Network Pharmacology and in vitro Experimental Verification
Journal: Combinatorial Chemistry & High Throughput Screening
DOI:
IF: 1.8
Application: WB
Reactivity: Human
Publish date: 2023 Mar
-
Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Mouse
Publish date: 2023 Jun
-
Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway
Journal: Aging (Albany Ny)
DOI:
IF: 5.2
Application: WB
Reactivity: Human
Publish date: 2023 Jun
-
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
Journal: Advanced Science
DOI:
IF: 15.1
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway
Journal: Phytomedicine
DOI:
IF: 6.656
Application: WB
Reactivity: Human
Publish date: 2023 Jan
-
Dasatinib causes keratinocyte apoptosis via inhibiting high mobility group Box 1-mediated mitophagy
Journal: Toxicology Letters
DOI:
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2023 Jan
-
Discovery of Novel 1,2,3,4-Tetrahydrobenzofuro[2,3-c]pyridine Histone Deacetylase Inhibitors for Efficient Treatment of Hepatocellular Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI:
IF: 7.3
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
Erianin Exerts Antineoplastic Effects on Esophageal Squamous Cell Carcinoma Cells by Activating the cGMP-PKG Signaling Pathway
Journal: Nutrition And Cancer-An International Journal
DOI:
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2023 Apr
-
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
Journal: Frontiers In Pharmacology
DOI:
IF: 5.988
Application: WB
Reactivity: Human
Publish date: 2023 Apr
-
Network-based pharmacology and in vitro validation reveal that galangin induces apoptosis in bladder cancer cells by promoting the p53 signaling pathway
Journal: Anti-Cancer Agents In Medicinal Chemistry
DOI:
IF: 2.527
Application: WB
Reactivity: Human
Publish date: 2022 Oct
-
Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics
Journal: European Journal Of Pharmacology
DOI: 10.1016/j.ejphar.2022.175035
IF: 5.195
Application: WB
Reactivity: Human
Publish date: 2022 May
-
N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
Journal: Molecular Cancer
DOI:
IF: 41.444
Application: WB
Reactivity: Human
Publish date: 2022 May
-
Reduced HMGB1 expression contributed to lapatinib-induced cutaneous injury
Journal: Research Square
DOI:
IF: NA
Application: WB
Reactivity: Human
Publish date: 2022 Mar
-
Chitosan-Coated Selenium Nanoparticles Attenuate PRRSV Replication and ROS/JNK-Mediated Apoptosis in vitro
Journal: International Journal Of Nanomedicine
DOI:
IF: 7.033
Application: WB
Reactivity: Monkey
Publish date: 2022 Jul
-
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
Journal: Cell Communication And Signaling
DOI:
IF: 7.525
Application: WB
Reactivity: Human
Publish date: 2022 Jul
-
Decreased HMGB1 expression contributed to cutaneous toxicity caused by lapatinib
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Mouse
Publish date: 2022 Jul
-
Phellinus baumii Polyphenol: A Potential Therapeutic Candidate against Lung Cancer Cells
Journal: International Journal Of Molecular Sciences
DOI:
IF: 6.208
Application: WB
Reactivity: Human
Publish date: 2022 Dec
-
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. Nature communications, 12(1), 1436.
Journal: Nature Communications
DOI:
IF: 12.121
Application: WB
Reactivity: Human
Publish date: 2021 Mar
-
Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis
Journal: Frontiers In Oncology
DOI:
IF: 6.24
Application: WB
Reactivity: Human
Publish date: 2021 Jun
-
Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors. Acta pharmacologica Sinica, 10.1038/s41401-020-00600-5. Advance online publication.
Journal: Acta Pharmacologica Sinica
DOI:
IF: 5.064
Application: WB
Reactivity: Human
Publish date: 2021 Jul
-
One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatin
Journal: European Journal Of Pharmacology
DOI: 10.1016/j.ejphar.2021.174366
IF: 4.432
Application: WB
Reactivity: Human
Publish date: 2021 Jul
-
Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 7.5
Application: WB
Reactivity: Human
Publish date: 2021 Dec
-
Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway
Journal: Molecular Medicine Reports
DOI:
IF: 1.851
Application: WB
Reactivity: Human
Publish date: 2019 Sep
Products with the same target and pathway
Cleaved PARP Recombinant Rabbit Monoclonal Antibody [SU0314] - BSA and Azide free
Application: WB,IF-Cell,IP
Reactivity: Human
Conjugate: unconjugated